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Background: Outbreaks of Foot-and-mouth disease (FMD) have resulted in tremendous economic losses. Thus, the
development of a rapid and easily performed test for FMD detection is important for controlling a FMD outbreak
and containing its spread. The purpose of this project is to develop a lateral flow immunochromatographic (LFI)
strip test for rapid detection of FMD virus serotypes O, A and Asia 1.
Methods: Specific monoclonal antibodies (mAbs) against each serotype were produced and used as the capture
mAbs. A serotype independent mAb was selected and used as the detection mAb with the aim of subsequently
developing a multi-serotype strip test. A new generation of the generic RapidAssay Device (gRAD) was used for
the test.
Result: Each strip test can specifically detect the FMDV O, A or Asia 1 viruses, but not other vesicular disease
viruses. The LFI strip tests for serotypes A and Asia 1 were able to identify all tested serotype A (n= 39) and Asia 1
field isolates (n=17). Whereas the test for serotype O detected 45 out of 46 field isolates. The sensitivity of this strip
test was comparable with the double antibody sandwich ELISA for viral antigen detection. All vesicular fluid and
epithelium samples collected from experimentally infected animals with serotype O, A and Asia 1 were identified
as positive by the LFI strip test. Swab samples (n=11) collected over the lesion area from experimentally inoculated
animals (serotype A) were examined. All of them demonstrated positive results using the LFI serotype A strip test
and double antibody sandwich (DAS) ELISA.
Conclusions: The ability of strip tests to produce rapid results and high specificity makes it a valuable tool for early
detection of FMDV O, A and Asia 1 in the field.
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strip testIntroduction
Foot-and-mouth disease (FMD) remains one of the world’s
most widespread epizootic and highly contagious animal
diseases. More than 100 countries are not yet recognized
as officially free of FMD by the World Organisation for
Animal Health (OIE). The rapid spread of the disease in
affected animals generates significant economic losses* Correspondence: Ming.Yang@inspection.gc.ca
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reproduction in any medium, provided the orworldwide. Based on serological tests, FMD virus (FMDV)
is recognized as seven serotypes: O, A, C, Asia 1, SAT 1,
SAT 2 and SAT 3. There are a large number of subtypes
within each serotype due to extensive genetic and anti-
genic variation among them [1,2]. Among the seven
serotypes of FMDV, O and A are the most widespread
and currently found in Africa, the Middle East, Asia,
limited area of South America and sporadically in Europe.
Asia 1 is primarily found in Asia, periodically into the
Middle East and occasionally Europe [3]. SAT 1, 2, and
3 are primarily restricted to Africa. Outbreaks of SAT 1d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of serotype C now appear extremely rare or may even have
totally disappeared; the last confirmed case was the
Amazon region of Brazil in 2004 and Kenya in 2005 [6,7].
The occurrence of FMD outbreak indicates the need to
develop rapid tests for early diagnosis in affected areas.
The rapid virus identification has important clinical,
economic, and epidemiological implications.
Various laboratory methods are currently available
for FMDV detection, including virus isolation, real-time
reverse-transcription (RRT) PCR and double antibody sand-
wich (DAS) enzyme-linked immunosorbent assay (ELISA).
Although the ELISA is relatively simple and easy to per-
form, it is difficult to perform the test in the field and take
hours to obtain results. These assays require laboratory
operations, well-trained personnel, and special equipment/
facilities. It would be impractical and excessively costly
for all countries to maintain a diagnostic laboratory with
full capabilities for confirmatory diagnosis of FMD. The
lateral flow immunochromatographic (LFI) strip tests
have been widely used for the diagnosis of many conta-
gious diseases and the detection of bioactive molecules,
such as hormones, haptens, and many others [7-9]. The
LFI strip test has many advantages including low cost,
short timeline for development, ease of performing and
result interpretation, minimum amount of training for
personnel and no special equipment required. The test
can be performed rapidly on-site during a major epi-
demic. Recently, LFI strip tests have been efficiently
applied to the detection of specific antibodies against
FMDV non-structural protein [10] and FMDV serotype
O [11]. The LFI strip tests have also been developed for
the detection of non-serotype specific FMDV [12,13]. The
availability of the non-serotype specific strip test would
allow for the on-site diagnosis of suspected FMD out-
breaks. A limiting factor for this non-serotype specific
strip test is that they are unable to identify the serotype of
FMDV, thus reducing their potential benefit in endemic
countries, where rapid identification of the serotype may
be essential to disease control [14]. The development of
the LFI strip test for single serotypes will be useful for
rapid detection in a secondary outbreak situation in which
the serotype was identified from the initial outbreak. It
can also be used to provide evidence of the disease spread-
ing around the initial outbreak, thus reducing the delay in
specimen submission for testing. The LFI strip tests were
developed for rapid testing of FMDV serotypes A and Asia
1 [15,16]. A strip test to identify FMDV serotypes O, A,
and Asia 1 has been reported [15]. However, polyclonal
sera from rabbits and guinea pigs were used as the cap-
ture and detection antibodies in their study. The use of
mAbs in the LFI test increases the specificity, accuracy,
consistency, efficiency of diagnosis and is easy to stan-
dardize compared with polyclonal antibodies.Of the seven serotypes, serotypes A, O and Asia are
more prevalent. The aim of this study was to produce
specific mAbs against FMDV O, A and Asia 1 and de-
velop serotype-specific LFI strip tests for the detection
of FMDV serotypes O, A and Asia 1 using a new gener-
ation of the generic RapidAssay Device (gRAD). In a
general LFI strip test, the specific detection antibody is
immobilized on the surface of the membrane so each
test device is custom made. This requires every single
test to be normalized, standardized, and validated. The
advantages of using the gRAD are that (1) there is no
need to spray specific antibodies or reagents to the mem-
brane, (2) it is ready to use for different tests with selected
specific antibodies, (3) the biotin-streptavidin system
will possibly enhance and improve the sensitivity of the
traditional LFI and (4) it is commercially available, which
makes assay development and standardization easier. In
addition, the pre-made gRAD is stable in storage for 2
years at room temperature. In this study, a serotype
independent mAb produced previously [17] was used
as the detection mAb to establish a foundation for
future development of a multiple serotype test in a
single device. The performance of each of the newly
developed LFI strip tests for FMD serotypes O, A, and
Asia 1 was compared with other methodologies for viral
antigen detection. Due to its ability to produce rapid re-
sults, the availability of the strip test would be useful for
early diagnosis of FMDV O, A and Asia 1 in an endemic
situation or during an epidemic. The LFI strip test can




The fusions were performed using mouse spleen cells
inoculated with BEI-inactivated viruses O1/Campos,
A22 /Iraq and Asia 1/Shamir. Three fusions for each
serotype were performed and allowed for the produc-
tion of 14 hybridomas for FMDV serotype O, 15 hybrid-
omas for serotype A and 2 hybridomas for serotype Asia
1 respectively. After the subcloning, the mAbs were des-
ignated and their isotypes were characterized. The
mAbs were examined for their reactivity and specificity
against different FMDV serotypes using FMDV serotype
specific DAS ELISAs. The results indicate that all mAbs
are FMDV specific without cross reactivity against other
vesicular disease viruses (data not shown).
Selection of detection mAb
Since the final goal is to develop a single strip test for
FMDV multi-serotype antigen detection, two serotype
independent FMDV specific mAbs, F14-12SA and F21-
140SO [17] were examined using a DAS ELISA to deter-
mine their suitability as a detection antibody. FMDV
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Two purified Asia 1 specific mAbs were coated onto
microtiter plates as the capture antibody. The antigen
binding was detected using two biotinylated serotype
independent mAbs as the detection mAb. The ELISA
results demonstrated excellent reactivity with mAb
F21-140SO (Figure 1a), while the other serotype inde-
pendent mAb F14-12SA was unable to detect the Asia
1 antigen in the DAS ELISA (Figure 1b). Thus, the mAb
F21-140SO was selected and used as the detection mAb in
the strip test. This mAb was purified and conjugated to
colloidal gold particles using Naked Gold in a Box™ .
Selection of capture mAbs
DAS ELISAs were used to select capture mAbs matching
the selected detection mAb for strip test development.
The ability of 15 serotype A specific mAbs was examined
to detect the different serotype A field isolates. A total of
39 FMDV serotype A field isolates were tested. The results
indicated that the mAb F66A22-14 reacted with all of the
isolates. Therefore the mAb F66A22-14 was selected and
used in the serotype A LFI strip test.
Two Asia 1 specific mAbs F34Asia-8 and F36Asia-14
were tested using a DAS ELISA. Monoclonal Ab F34Asia-8
demonstrated low binding affinity to Asia 1/IRN31/2004
and failed to react with Asia 1/KRG1/2004 (data not
shown). While the mAb F36-14 failed to react with an
Asia 1/IND 8/79 isolate and showed lower binding
affinity to five newly isolated FMDV Asia 1 strains. The
use of single mAb may not be able to recognize all isolates
when antigenic evolution occurs. To overcome the limita-
tion of a single mAb binding one epitope and increase the
detection strain variety, it was decided to combine twoFigure 1 Selection of detection mAbs using a DAS ELISA. Two purified
Then the FMDV Asia 1/Shamir and Asia 1/Pakistan 1/54 antigens were add
serotype independent mAbs: (a) mAb F21-140SO and (b) mAb F14-12SA. TAsia 1 specific mAbs as the capture mAbs. The mAb
F34Asia-8 showed neutralization activity against Asia 1/
Shamir, while the mAb F36Asia-14 did not, suggesting
that the binding sites of these two Asia 1 specific mAbs
were different from each other.
For serotype O capture mAb selection, the reactivity
of 14 serotype O specific mAbs with 46 serotype O field
isolates were examined using a DAS ELISA. One (F1O-
2-5) out of 14 serotype O specific mAbs reacted with
45 out of 46 serotype O isolates, but failed to bind with
O/ECU4/10. It is possible that mutations occurred for
O/ECU4/10 on mAb (F1O-2-5) binding site. Since the
mAb F1O-2-5 is the one that reacted with most of sero-
type O isolates, it was selected and used as the capture
mAb in the LFI strip test. All mAbs selected for the LFI
strip test failed to react with the denatured viruses using
an indirect ELISA, which suggests that the epitopes rec-
ognized by them were conformational. The character-
izations of the selected capture mAbs are shown in
Table 1. They were purified, biotinylated and ready for
use in the LFI strip test.Immunochromatographic strip test development
The gRAD was selected and used for the strip test devel-
opment. In the test, the mixture of the viral antigen with
serotype specific biotinlyted capture mAb and colloidal-
gold conjugated serotype independent detection mAb
were applied to the gRAD and migrated along the mem-
brane. The immune complex reacted with the immobilized
biotin-binding protein on the test line making the test line
visible, while the remainder reagents continued to migrate.
The colloidal-gold conjugated detection mAb bound to themAbs (F34Asia-8 and F36Asia-14) were coated onto microtiter plates.
ed to the plates. The antigen binding was detected with biotinylated
he binding was detected with an avidin-HRP conjugate (1:2000).
Table 1 Characterization of capture mAbs against FMDV serotype O, A, and Asia 1
MAbs Inoculation virus Serotype specificity Isotype Epitope VNT
F1O-2-5 O1 Campos O IgG1k Conformational -
F66A22-14 A22 Iraq A IgG2a/k Conformational +
F34Asia-8 Asia 1 Shamir Asia 1 IgG2a/k Conformational +
F36Asia-14 Asia 1 Shamir Asia 1 IgG1/k Conformational -
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(Figure 2).
Initially, 20 nm colloidal-gold particles were used for
conjugation with the detection mAb. However, the sensi-
tivity of the strip test was much lower than that of the
DAS ELISA in the preliminary study. Since the diameter
of colloidal gold particles may affect the sensitivity of
the tests, different sized colloidal-gold particles (20 nm,
40 nm and 60 nm) were examined. With the purpose of
sensitivity comparison, a serial dilution of viral antigen
was used instead of using protein concentration or
TCID50. The test result showed a higher sensitivity with
60 nm colloidal-gold particles conjugated to the detec-
tion mAb compared to 20 nm and 40 nm colloidal-gold
particles. At a FMDV Asia 1 antigen dilution level of
1:256, only 60 nm colloidal-gold conjugated mAb was
positive. The reading results by an ESE-Quant Lateral
Flow Reader confirmed the finding by visual assessment
(Table 2). Based on the results, 60 nm colloidal-goldFigure 2 Schematic diagram of the immunochromatographic
strip test using the gRAD. The test line contains a biotin-binding
protein that captures biotinylated capture mAb. The control line
contains antibodies that bind the mouse antibody which is
responsible for immobilizing the detection conjugate at the control
line. When testing, samples were mixed with both the biotinylated
capture mAb and the detection colloidal-gold mAb conjugate to
form a complex in the running buffer. Then 100 μl of the mixture is
applied to the sample well of the gRAD. The mixture migrates along
the membrane of the gRAD to the test line which binds and
immobilises the biotinylated capture antibody. After 10 minutes,
results were determined by visualization. A positive result following
the accumulation of complex (biotinylated capture mAb, FMDV and
Colloid gold-mAb) is demonstrated by the appearance of reddish-
purple bands at both the test line (T) and the control line (C). A
negative result is demonstrated by a reddish-purple band at the
control line only.particles were selected and utilized in the test. The
colloidal-gold conjugated detection mAb at 0.2 μg/test
gave the highest sensitivity for viral antigen detection
with very low background and without false positive
results.
LFI test specificity
With the intention of determining analytical specificity,
culture supernatants of the 7 serotypes of FMDV and of
other vesicular disease viruses (Swine vesicular disease
viruses; Vesicular stomatitis viruses; Seneca valley vi-
ruses; and Vesicular exanthema of swine virus) were ex-
amined using the LFI strip tests for each serotype. The
specific FMDV viruses demonstrated a strong band on
the test line for serotypes O, A and Asia 1 respectively
(Figure 3). But the LFI strip test for serotype A demon-
strated cross reactivity with 4 out of 9 tested serotype C
(C/KEN 1/2004, C/Noville, C/Oberbayern and C/Resende).
All other un-related FMDV serotypes and non-FMD
vesicular disease viruses showed negative results with
no visible band on the test line (Table 3). Thirteen epi-
thelial samples were collected from naïve animals (cattle,
pig and sheep). 10% tissue suspensions were prepared and
tested using the LFI strip test. All these samples failed to
show any visible band on the test line. Because of limited
number of negative samples, it is impossible to determine
the diagnostic specificity. More negative samples need to
be examined.
The ability of the LFI strip test to detect the different
isolates for each serotype was examined. All 39 serotype
A field isolates were tested demonstrated positive results
using the LFI strip test (Table 3). For serotype O, the
results showed strong bands on the test line for 44 out
of 46 isolates, but a relatively weak band for O/MAY/1/
05 and failed to detect O/ECU4/2010 isolate. This virus
sample was identified as a positive result using the
double polyclonal antibody sandwich ELISA with the
optical density (O.D.) reading of 0.231. A mean O.D.
value ≥0.1 in the ELISA was measured as positive re-
sponse. For Asia 1, the test results demonstrated that
the strip test was able to identify all the FMDV Asia 1
isolates (n=17) by combining two Asia 1 specific capture
mAbs. The LFI strip test has slightly different levels of
sensitivity for different Asia 1 isolates. The test line density
for six isolates (Asia 1/IRN 31/04; Asia 1/KRG 1/04, Asia
1/VIT 15/05; Asia 1/MYA 1/05 and Asia 1/VIT 8/06) on
Table 2 Comparison of different sizes of colloidal-gold particle conjugated detection mAb in the strip test
Gold particle size 20 nm 40 nm 60 nm
Antigen dilution ESE reading Visible band ESE reading Visible band ESE reading Visible band
1:16 109.93 + 244.52 ++ 226.84 ++
1:32 63.07 + 174.40 + 237.03 ++
1:64 31.57 + 95.69 + 142.10 ++
1:128 16.14 - 43.23 + 88.09 +
1:256 18.79 - 19.21 - 25.43 +
FMDV Asia 1 Shamir (2-fold dilution, 50 μl) was mixed with 1 μl of each biotinylated F34Asia-8, F36Asia-14 and 6 μl mAb (F21-140SO) conjugated with different
size of colloidal-gold in the running buffer. The mixture (100 μl) was applied to the gRAD. After 10 minutes, the result was recorded. + +: Strong band; +: Light
band; -: No visible band.
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virus contents were similar indicated by TCID50/ml. This
indicates that the sensitivity of the strip test might be
slightly different for diverse FMDV strains. Above results
indicated that the LFI strip tests for serotype O and Asia 1
are specific, with no cross reactions with other FMDV se-
rotypes and vesicular disease viruses. While the LFI test
for serotype A showed a cross reactivity with 4 isolates of
serotype C, but without cross reaction with other vesicular
disease viruses.
LFI test sensitivity
Tissue suspension (10%) made from epithelial lesions
collected from pigs experimentally inoculated with the
FMDV serotypes O, A and Asia 1 were two-fold serially
diluted in PBS. The sensitivity of the strip test was evalu-
ated and compared with that of the DAS ELISA. In the
strip test, the densities of the band on the test lines grad-
ually declined from strong to weak indicating that the
test is dose dependent (Table 4). ESE reading for the LFIFigure 3 Specificity of the strip test. Culture supernatants containing th
capture mAbs (F1O-2-5 for serotype O, F66A22-14 for serotype A and F34A
conjugated F21-140SO in the running buffer (50 μl). The mixture (100 μl) w
the test line and C is the control line. (a). The LFI strip test for serotype O; (test is correlated with the O.D. value in the DAS ELISA.
Samples of 50 μl with a viral titer > 2.55 log10 TCID50/ml
for serotype O, > 5.2 log10TCID 50/ml for serotype A and
> 6.3 log10TCID 50/ml for Asia 1 produced a visible test
line. The LFI strip test for different serotype revealed dif-
ferent test sensitivity. However, the sensitivity of the LFI
strip test is equivalent to that of the DAS ELISA for the
serotypes O and Asia 1. The LFI strip test for serotype
A is one to two dilutions less sensitive than the DAS
ELISA.
Validation of the LFI strip test with samples from
experimentally inoculated animals
To evaluate whether the LFI strip tests for three sero-
types are able to detect FMD viral antigens in clinical
samples, tissue suspensions and vesicular fluid collected
from experimentally inoculated animals with FMDV
serotypes O, A and Asia 1 were tested using the LFI
strip test, DAS ELISA and RRT-PCR [18]. As shown
in Table 5, all samples of vesicular fluids and epitheliae seven serotypes of FMDV (50 μl) was mixed with 1 μl of biotinylated
sia-8, F36Asia-14 for serotype Asia 1) and 6 μl of colloidal-gold
as applied to the gRAD. After 10 minutes, the result was recorded. T is
b). for serotype A and (c). for serotype Asia 1.
Table 3 The LFI strip test results for FMDV seven
serotypes and other vesicular disease viruses
Virus Serotype O Serotype A Serotype Asia 1
FMDV O 45/46 0/46 0/46
FMDV A 0/39 39/39 0/39
FMDV Asia 1 0/17 0/17 17/17
FMDV C 0/9 4/9 0/9
FMDV SAT 1 0/11 0/11 0/11
FMDV SAT 2 0/19 0/19 0/19
FMDV SAT 3 0/4 0/4 0/4
SVDV 0/4 0/4 0/4
VSV (IN&NJ) 0/6 0/6 0/6
SVV 0/1 0/1 0/1
VESV 0/1 0/1 0/1
Viruses in culture supernatants (50 μl) were mixed with 1 μl of each
biotinylated capture mAb for each serotype and 6 μl of colloidal-gold
conjugated F21-140SO in the running buffer. The mixture (100 μl) was applied
to the gRAD. After 10 minutes, the result was recorded.
SVDV: Swine vesicular disease viruses; VSV: Vesicular stomatitis viruses; IN:
Indiana; NJ: New Jersey; SVV: Seneca valley viruses; VESV: vesicular Exanthema
of swine virus.
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bands) collected from these animals were identified as
positive by the LFI strip test, DAS ELISA and RRT-
PCR. The use of 1 μl of vesicular fluid in the LFI strip
test also demonstrated a positive result.
The aim of the current project is to apply the LFI strip
test in the field. However, preparation of 10% tissue
suspensions on site may be difficult. To make sample
preparation procedure straightforward, samples collected
from or over the ruptured lesion areas using nylon flocked
swabs were tested. A total of 11 swab samples were col-
lected from 4 pigs experimentally inoculated with FMDV
A22 /Iraq. All of them demonstrated positive results using
the LFI serotype A strip test and the DAS ELISA (Table 6).
The test results of swab samples were also compared
with tissue suspension (Figure 4). It was observed that
viral antigens in both tissue suspension and swab sam-
ples obtained around the lesion area demonstrated posi-
tive bands on the test lines, and two of swab samples
showed lighter testing bands than 10% tissue suspen-
sions. It is demonstrated that this procedure is simple
and can be easily accomplished in the field. To con-
clude, the strip tests for FMDV serotypes O, A, and Asia
1 are specific and suitable for detecting the FMDV anti-
gen in vesicular fluid, epithelia suspensions and swabs
collected over the lesion area.
Amino acid alterations on mAb binding site of the virus
cause the failure of viral detection
The mAb F1O-2-5 used in the LFI strip test for serotype
O was unable to react with isolate O/ECU/ 4/10 and
showed weak binding with O/MAY/1/05. Therefore, theP1 gene sequences of the two isolates were sequenced
and compared with those of the FMDV O1/Campos
and 43 additional FMDV O viruses (unpublished data).
Six unique mutations in VP1, 4 of them located on
previously identified antigenic sites [19]; three unique
mutations in VP2, and seven unique mutations in VP3
(1 on antigenic site) were observed for O/ECU/4/10
[GenBank: KC519630] One unique mutation in VP3 at
amino acid position 73 was found to be shared by O/
ECU/4/10 (Val→Leu) and O/MAY/1/05 (Val→Glu)
[GeneBank: KC519631] (Figure 5). Amino acid alter-
ation at this position may led to loss of binding cap-
acity of mAb with O/ECU/4/10 and reduced binding
capacity of mAb with O/MAY/1/05 in the LFI strip test.
This indicated that the binding epitope of the capture
mAb for serotype O F1O-2-5 is located in VP3 around
amino acid position 73.
Discussion
Outbreaks of FMD have resulted in tremendous eco-
nomic losses. Thus, the development of a rapid and eas-
ily performed test for FMD detection is important for
controlling a FMD outbreak and containing its spread.
The LFI strip test was developed as a method suited for
laboratories and on-site for rapid FMD viral antigen
detection. Monoclonal antibodies were used for this test
because the use of mAbs in the test increases the speci-
ficity, accuracy, consistency and efficiency of diagnosis
compared with polyclonal antibodies. Monoclonal Abs
were produced from mice inoculated with BEI-inactivated
FMDV serotypes O, A, or Asia 1. Based on the DAS
ELISA results, mAbs F1O-2-5, F66A22-14 and F34Asia-8,
F36Asia-14 were selected and used as the capture mAbs
for serotype O, A, Asia 1 LFI strip tests respectively.
The selected serotype A capture mAb reacted with all
tested field isolates, while the serotype O capture mAb
failed to react with one (O/ECU4/10) out of 46 isolates.
The two Asia 1 specific mAbs demonstrated low bind-
ing affinity to some strains and failed to react with at
least one of the tested strains. To increase the sensitivity
and detection range of Asia 1 strains, the combination
of the two FMDV Asia 1 specific mAbs were used as the
capture antibody. This would overcome the limitation
of a single mAb binding one epitope since using only
one capture mAb may reduce the ability to recognize
viruses when antigenic evolution occurs. The capture
mAbs selected for O and Asia 1 were shown to react
with FMDV specific serotype, while the mAb used for
serotype A demonstrated cross-reactivity with four of
the nine tested serotype C isolates. The mAb F66A22-14
was selected for serotype A since it is the only mAb that
reacts with 39 field isolates. Although this mAb showed
cross-reactivity to some of the serotype C isolates, it is
better than missing isolates when used for diagnosis. In





Strip test DAS ELISA
ESE reading Visual OD Results
Serotype O
Epithelial lesion 1:4 4.05 479 ++ 2.208 +
(Pig14) 1:8 3.75 345 ++ 1.796 +
1:16 3.45 252 ++ 1.207 +
1:32 3.15 132 ++ 0.658 +
1:64 2.85 60 + 0.227 +
1:128 2.55 27 + 0.168 +
1:256 2.25 14 - 0.06 -
Serotype A
Pig 80 Interdigital 1:2 6.7 672 ++ 2.405 +
1:4 6.4 534 + 2.298 +
1:8 6.1 407 ++ 2.007 +
1:16 5.8 204 + 1.481 +
1:32 5.5 83 + 0.884 +
1:64 5.2 33 ± 0.461 +
1:128 4.9 33 - 0.153 +
Serotype Asia 1
Coronary 1:2 7.8 NA ++ 1.989 +
Band 1:4 7.5 NA ++ 1.65 +
1:8 7.2 NA ++ 1.196 +
1:16 6.9 NA + 0.746 +
1:32 6.6 NA + 0.379 +
1:64 6.3 NA + 0.177 +
1:128 6.0 NA - 0.055 -
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since 2005.
A FMDV serotype independent mAb F21140SO-42
[17] was used as the detector in the strip test. Using one
serotype independent mAb as detection antibody has an
advantage for the future development of a multi serotype
LFI strip test using a single device. An important consid-
eration in designing an LFI strip test when using mAbs
is that the capture and detection antibodies should
recognize different non-overlapping epitopes. When the
antigen binds to the capture antibody, the epitope recog-
nized by the detection antibody should not be hidden.
DAS ELISAs were used to confirm that the antibody pair
(capture and detection) did not interfere or compete
with the same binding epitope before the LFI test devel-
opment. This will prevent reduced sensitivity in the test.
The detection mAb was conjugated to colloidal gold
particles using Naked Gold in a Box™. The kit is easy to
use for preparation of highly reactive gold conjugates.
The procedure allows us to quickly determine the opti-
mal colloidal gold binding conditions for attaching tothe Fc portion of mAbs. The resulting gold particles are
highly active and can be directly used in strip tests. The
test result showed a higher sensitivity using 60 nm col-
loidal gold particles conjugated with the detection mAb
compared with 20 and 40 nm colloidal gold particles. At
an antigen dilution level of 1:256, only 60nm gold parti-
cles scored positive results. 60nm colloidal gold particles
were selected and used for the study. This is a clear indi-
cation that the density of color showing on the strip is
closely related to the size of the colloidal gold particles.
Analysis of the specificity demonstrated that the strip
tests for serotype O and Asia 1 were specific. The sam-
ples containing the other serotypes of FMDV as well as
other vesicular disease viruses were all negative in the
strip test (Table 3). The LFI strip test for serotype A
showed positive results for four serotype C field isolates,
besides the serotype A samples. The reason for the cross
reactivity is uncertain. It is possible that some mutations
occurred close to the mAb binding epitope in these
serotype C isolates. Thirteen negative epithelial samples
were tested using the LFI strip test for all three serotypes
Table 5 FMDV serotype O, A, and Asia 1 detection using
different methods for samples collected from
experimentally inoculated animals




Tongue 4/4 4/4 4/4
Epithelial lesion 4/4 4/4 4/4
Interdigital area/coronary band 2/2 2/2 2/2
Vesicular fluid 2/2 2/2 2/2
Cow
Tongue 2/2 2/2 2/2
Coronary band 1/1 1/1 1/1
Interdigital area 2/2 2/2 2/2
Vesicular fluid 2/2 2/2 2/2
Serotype A (pig)
Tongue 4/4 4/4 4/4
Coronary band 4/4 4/4 4/4
Interdigital area 4/4 4/4 4/4
Vesicular fluid 1/1 1/1 1/1
Serotype Asia 1 (pig)
Tongue 2/2 2/2 2/2
Coronary band 4/4 4/4 4/4
Interdigital area 4/4 4/4 4/4
Vesicular fluid 4/4 4/4 4/4
Pos/total: Tested positive numbers/total tested samples.
Figure 4 Comparison of LFI test for tissue suspensions and
lesion swabs. Tissue suspensions and flocked swabs over lesions
collected from 4 experimentally inoculated pigs with A22 Iraq.
Samples (a. tissue suspension, b. lesion swab sample, 50 μl) were
mixed with 1 μl of biotinylated F66 A22-14 and 6 μl of colloidal gold
conjugated F21-140SO in the running buffer. The mixture (100 μl)
was applied to the gRAD. After 10 minutes, the result was recorded.
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diagnostic specificity, because of small number of nega-
tive samples tested. The sensitivity of the LFI strip test is
equivalent to that of the DAS ELISA for the serotypes O
and Asia 1 using the tissue samples collected fromTable 6 LFI strip test and DAS ELISA results of swab
samples collected from pigs experimentally inoculated
with FMDV A22 /Iraq
LFI strip test DAS ELISA (OD)
Pig 77 Swap 1 + 1.717
Swap 2 + 1.3
Swap 3 + 0.307
Pig 78 Swap 1 + 0.604
Pig 79 Swap 1 + 1.589
Swap 2 + 0.833
Swap 3 + 2.04
Pig 80 Swap 1 + 3.079
Swap 2 + 3.372
Swap 3 + 2.713
Swap 4 + 2.918experimentally inoculated pigs. The LFI strip test for
serotype A is one to two dilutions less sensitive than the
DAS ELISA. The LFI strip test’s sensitivity is similar to
the results reported by Lin et al. [20].
The aim for the LFI strip test is to detect FMDV viral
antigens from clinical samples. Vesicular liquids and epi-
thelia collected from the experimentally inoculated ani-
mals (pigs and cows) were examined and the LFI strip
test correctly revealed positive results. To obtain full val-
idation of the strip test more of these samples need to
be tested since no field samples were examined in the
current study. Similar to the ELISA, the sensitivity of the
LFI strip test is lower when compared with the RRT-
PCR [21]. Both the LFI strip test and the DAS ELISA
were unable to consistently detect viral antigen in the
samples collected from nasal swabs and sera which were
positively identified by the RRT-PCR. This result is con-
sistent with Ferris’s finding that the LFI strip test is
Figure 5 Localization of a unique amino acid change at same site shared by FMD O/ECU/4/10 and O/MAY/1/05 in capsid protein.
(a) Low-resolution overview of the reduced serotype O capsid structure (prepared with Chimera). (b) Blow-up of capsid crystal asymmetric
unit (PDB # 1FOD) corresponding to colored region in “A” consisting of one VP1 protein (yellow), one VP2 protein (green), and one VP3
protein (cyan) depicted as surface model and one VP4 protein (blue) in cartoon format, with O/ECU/4/10 (Val73→Leu) and O/MAY/1/05
(Val73→Glu) unique mutations shown in red.
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epithelia due to limitation of test sensitivity [13]. There-
fore, it is not suitable to use the LFI test for virus detec-
tion in nasal swabs and serum samples where the number
of virus particles may not be sufficient for both the LFI
strip test and ELISA.
Ferris [13] indicated that for epithelia, the sample must
be homogenized to release virus antigen from the tissue.
However it is difficult to prepare 10% tissue suspensions
in the field. To make the sample preparation procedure
straightforward, swab samples collected over the lesion
area were examined. All of them (n= 11) demonstrated
positive results using the serotype A LFI strip test and
the DAS ELISA. It is possible that viruses were released
because vesicles often rupture rapidly and becoming
erosions. This makes the sample preparation procedure
simpler than preparing the 10% epithelia suspension and
can be easily done in the field. The use of flocked swabs
increased surface area which might result in better virus
recovery rates than when using the conventional swabs
[22]. A combination of two swabs per vial for this study
may also increase the amount of viral particles, thus
enhancing test sensitivity.
The strip test has many advantages including low cost,
short timeline for development of results, ease of result
interpretation and no requirement for special equipment
or highly trained personnel. However, it also has limitationsthat include the inability to provide qualitative or semi-
qualitative results. In this study, an ESE lateral flow reader
was used to confirm the results by visual reading. A good
correlation between the readout by the reader and visual
reading was observed. However, some false readings were
observed using the ESE reader. Some negative samples
without a visible band on the test line showed a reading
higher than some of the positive samples with visible bands.
A possible explanation for the false positive may be position
errors in the reading window and device housing making it
difficult to determine the cut-off value. For research pur-
poses, the ESE reading value can be used to confirm visual
reading and calculate the correlation with other test results.
The capture mAb used for serotype O in the LFI strip
test does not react with O/ECU/4/10 and has a low
binding affinity with O/MAY/1/05. To provide a com-
pleted picture at nucleotide level for capsid genes, the
P1 regions of the two isolates that encode capsid pro-
teins were sequenced and compared with those of mAb
derivative strain O1/Campose and additional 44 field
isolates available in the laboratory. In consistence with
VP1 sequences reported by Maradei [28], O/ECU/4/10
had an amino acid deletion near the antigenic site 1 within
the VP1 GH loop. In their report, the mAb profiling
showed loss of reactivity of most of the O/ECU 2010’s
viral samples with four mAbs, three of them with neu-
tralizing properties. Levels of protective antibodies
Yang et al. Virology Journal 2013, 10:125 Page 10 of 13
http://www.virologyj.com/content/10/1/125induced by the vaccine against the field strains also
pointed to a loss of a protective response against O/
ECU4/10. The sequence data revealed that O/ECU/4/10
has many unique amino acid alterations within the surface
capsid proteins (i.e. VP1, VP2, and VP3). Interestingly
however, the amino acid change in VP3 at position 73 was
only observed from O/ECU/4/10 and O/MAY/1/05. It is
assumed that the epitope of mAb F1O-2-5 applied in the
strip test resides on amino acid position around 73 in the
VP3 protein. The changes in the binding site because of
the amino acid substation led to loss of binding capacity
of O/ECU/4/10 and reduced binding affinity of O/MAY/
1/05 with mAb F1O-2-5. More mAbs against FMDV sero-
type O will be produced and screened. Eventually, one
mAb recognizing a conserved epitope, thus reacting with
all field isolates will be produced and used in the LFI test.
All of the mAbs used in the LFI strip test recognize
conformational epitopes since they do not bind dena-
tured viruses in the indirect ELISA. If the virus in the
sample is denatured during environmental conditions or
transportation, the denatured viruses will not be detected
using this LFI strip test. The sensitivity of the strip test
may be slightly different for diverse FMDV strains. An
explanation for this may be that FMD viruses undergo
frequent mutations that result in changes of structural
proteins. Conformations of binding epitopes may also
change in the process. The binding affinity of mAbs
would be reduced against changed epitopes as all mAbs
used in the LFI strip test recognize conformational
epitopes.
Conclusions
The LFI strip tests for FMDV serotypes O, A and Asia 1
have been developed and achieved sensitivity similar
to that of the ELISA in a procedure that takes only 10
minutes. The serotype specific capture mAbs (O, A
and Asia 1) and one serotype independent detection
mAb with high binding affinity to all FMDV serotypes
are crucial to the high specificity and sensitivity re-
quirement for the strip test development. The gRAD
and the colloidal conjugated detection mAb are suited
for different serotype strip tests without modification
of the device. The LFI strip tests developed in this study
have great potential for on-site FMDV serotypes O, A,
and Asia 1 diagnosis to confirm clinical findings in FMD-
endemic areas lacking highly specialized staff or can be
used as a screen test in laboratories. However, the newly
developed LFI strip test needs to be further standardized
to achieve optimal diagnostic sensitivity and specificity.
The current LFI strip test allows the detection of a single
serotype using each gRAD device. A FMDV multiple
serotype antigen detection using a single device will be
developed where the capture mAbs will be labelled with
different tags and the serotype independent detectionmAb will be used. The ability of the LFI strip test to
produce rapid results and high specificity makes it a
valuable tool for early diagnosis of FMD.
Materials and methods
Ethics statement
The animal use and procedures in this study was approved
by the Canadian Science Centre for Human and Animal
Health Animal Care Committee (Animal use document
#C-11-003).
Preparation of FMDV
All of the FMDV isolates used in this study were obtained
from the FAO/OIE World Reference Laboratory for FMD
at the Pirbright Institute, Pirbright, UK.
Baby hamster kidney clone, 21 cells (BHK-21) were
cultured in Glasgow’s MEM supplemented with 2 mM
L-glutamine and 50 μg/ml gentamycin and infected with
FMDV. Viruses were harvested 24 hours post-infection
and clarified by centrifugation at 8000 g for 30 minutes.
For inactivation of the virus, 10 mM 2-Bromoethylamine
Hydrobromide (BEI) was added to cell culture supernatants
containing viruses and inactivated for 24 hour at 37°C.
After 24 hours, any remaining BEI was inactivated using
Sodium Thiosulphate to a final concentration of 2%. The
inactivated FMDV Asia 1 Shamir strain was concentrated
and purified for mice inoculation. Briefly, tissue culture
supernatant containing virus was mixed with 50% poly-
ethylene glycol (PEG, MW 8000) to a final concentration of
7.5% and stirred for 12 hours at 4°C. The precipitate was
obtained by centrifugation and resuspended in Tris-NaCl
Buffer (150 mM NaCl, 50 mM Tris pH 7.8). The concen-
trated virus was layered onto 15-45% sucrose density gradi-
ent and ultracentrifuged at 27,000 rpm for 2.5 hours at 4°C.
The whole virus (140S) band was collected.
Denatured virus was prepared by adding 10 μl of 10%
SDS and 10 μl of 1M Dithiothreitol (DTT) to 100 μl of
purified virus. The mixture was heated for 5 minutes at
95°C. The denatured antigen was then diluted to assay
concentrations in a buffer and used for coating antigens
in indirect ELISAs with no further treatment.
Production of monoclonal antibodies
Mice immunizations and mAb production were performed
as previously described [17]. Briefly, female BALB/C mice
were inoculated subcutaneously with purified and BEI
inactivated FMDV (20 μg/mouse) in an equal volume of
TiterMax Gold (TiterMax USA Inc., Norcross, USA).
Two to three identical boosts were administered at four
week intervals. Mice were boosted with the same anti-
gen in phosphate-buffered saline (PBS) by intravenous
injection 3–4 days prior to the mice being euthanized
for the purpose of spleen cell collection. Immunized
spleen cells were fused with myeloma cells (P3X63
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hybridoma supernatants were screened using FMDV
serotype specific DAS ELISAs. The positive clones were
subcloned using a limiting dilution method. Isotyping
was performed, using a mouse monoclonal antibody
isotyping kit (Roche, Indianapolis, IN, USA).Purification of monoclonal antibody
The hybridomas were grown in BD Cell MAb medium
(Becton, Dickinson and company, MD, USA) supplemented
with 2% fetal bovine serum. After 7 days culture, the culture
supernatants were harvested and concentrated. The mAbs
were purified from hybridoma culture supernatants by a
HiTrap Protein-G affinity column (GE, Fairfield, CT, USA)
using an AKIA chromatography system according to manu-
facturer’s instruction.Biotinylation of mAb
The purified mAb was dialyzed against 0.1 M NaHCO3,
pH 8.4 at 4°C. A biotin-spacer conjugate (D-Biotinoyl-ε-
Aminocaproic Acid N-hydroxysuccinimide Ester, Sigma-
Aldrich, St Lucia, MO, USA) was dissolved in anhydrous
DMSO (Sigma-Aldrich, St Lucia, MO, USA) at 8mg/ml
and then added to the antibody (Biotin-spacer:mAb, 80 μg:
mg). The reaction was allowed to proceed for 1 hour at
room temperature in the dark, following which unbound
biotin was removed by extensive dialysis against PBS at 4°C.
The reagent was stored at 4°C in PBS with 0.01%NaN3.Double antibody sandwich (DAS) ELISA for detection
antibody selection
Microtitre plates (Nunc-Immunoplate Maxisorp, Roskilde,
Denmark) were coated with purified anti-FMDV Asia 1
mAbs diluted in 0.06 M carbonate/bicarbonate buffer,
pH 9.6 and incubated overnight at 4°C. The plates were
blocked with 5% skim milk in PBS with 0.05% Tween 20
at 37°C for 1 hour. The FMDV Asia 1 antigen diluted in
PBS with 5% skim milk and 0.05% Tween 20 was added to
the plates and then the biotin-conjugated FMDV serotype
independent mAbs were added. After an incubation step,
the horseradish peroxidase (HRP)-conjugated strept-avidin
(1:2000, Jackson ImmunoResearch Laboratories, West
Grove, PA, USA) was used and then O-phenylenediamine
dihydrochloride (OPD, Sigma-Aldrich, St Lucia, MO, USA)
was added. An equal volume of 2.0 M sulfuric acid was
added to each well to stop the color reaction. The optical
absorbance was measured at 490 nm using an automated
plate reader (Photometer Multiskan Reader, Labsystems,
Foster, VA, USA). Each incubation step was 60 minutes at
37°C with gentle shaking and followed by washing three
times with washing buffer.Colloidal-gold conjugate detection mAb
The detection mAb was conjugated to colloidal gold
particles using a Naked Gold in a Box™ (Rapid Assay,
Copenhagen, Denmark). For optimal binding of the anti-
body, the pH of the gold solution was adjusted to 7.8,
slightly above the iso-electric point of the mAb through a
series of pH titration with buffers. The mAb (33 μg in
PBS) was mixed with 1 ml of colloidal-gold solution. The
mixture was stirred vigorously for 30 minutes and then
100 μl of the blocking buffer was added, followed by in-
cubation at room temperature overnight. The resulting
conjugated colloidal-gold mAb is ready for use.
Animal experiments
All procedures involving experimental animal inocula-
tions and care were performed following the Canadian
Council of Animal Care guidelines. Four pigs for each
serotype (O, A and Asia 1) and two cows for serotype O
were inoculated with BHK-21 cell culture supernatant
containing FMDV O/UKG/34/2001, A/IRN/1/2009 or Asia
1/PAK20/2003 (6–7 log10 50% tissue culture infecting dose
(TCID50/ml) /animal) through the intra-lingual (cattle), the
heel bulb (pigs) and the coronary band. Vesicular fluid,
coronary band, interdigital epithelium and tongue were
collected on 3–4 days post inoculation (dpi) in 5 ml
phosphate buffered transport medium.
Tissue sample preparation
The tissue samples (1g) for testing were emulsified using
a sterile mortar and pestle with Dulbecco's PBS as dilu-
ent to make a 10% Weight/Volume suspension [23]. The
suspension was clarified by centrifugation at 2000 x g
(3000 rpm) at 4°C for 20 minutes and the supernatant
was harvested. An antibiotic stock solution was added to
the supernatant to obtain 10% concentration. The mix-
ture was incubated at room temperature for 30 minutes.
This preparation is the undiluted 100 sample.
Nylon flocked swabs (Puritan medical products com-
pany LLC, USA) were used for collecting swab samples
over ruptured lesion areas. The dried nylon flocked swabs
were rubbed and rolled firmly several times across or over
the lesion area. Two swabs from each lesion area were
inserted into a tube containing 1 ml PBS. The samples
were stored at −70°C until testing.
Immunochromatographic strip test
The RapidAssay Devices were purchased from the Rapid
Assays (Copenhagen, Denmark). The test line contains a
biotin-binding protein that captures both complexed
and free biotinylated capture mAb. The control line
contains antibodies that bind the mouse antibody which
is responsible for immobilizing the detection conjugate
at the control line. When testing, virus in samples were
mixed with the serotype specific biotinylated capture
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form a complex in the running buffer (Rapid Assays,
Copenhagen, Denmark). Then 100μl of the mixture was
applied to the well of the gRAD. The mixture migrated
along the membrane of the gRAD to the test line which
binds and immobilises the biotinylated capture anti-
body. After 10 minutes, results were determined either
by visualization or an ESE-Quant Lateral Flow Reader
(ESE GmbH, Stockach, Germany). A positive result fol-
lowing the accumulation of complex (biotinylated cap-
ture mAb, FMDV antigen and Colloid gold-mAb) was
demonstrated by the appearance of reddish-purple
bands at both the test line (T) and the control line (C)
(Figure 2). A negative result was demonstrated by a
reddish-purple band at the control line only.
Sequencing FMDV O P1 gene
Genomic RNA was extracted from laboratory stocks
using the Rneasy Mini Kit (Qiagen, Venlo, Netherlands).
Terminal oligonucleotide primers complementary to
the L gene (5’-TTCTGGTGTTTGTCCCGTACGAT-3’)
(Invitrogen, Carlsband, USA) and 2B gene (5’-GTTGACAT
GTCCTCCTGCATCTG-3’) for reverse transcription-PCR
and additional ones for internal sequencing were chosen
from the most conserved sequence region by alignments
of available FMDV O whole genome sequences from
GeneBank. Full-length cDNA copies of the P1 genes of
each virus were synthesized from genomic RNA by
using the terminal primers and SuperScript™ III reverse
transcriptase (Invitrogen, Carlsband, USA). The cDNAs
were amplified by PCR using the Expand™ Long Tem-
plate PCR system according to the manufacturer’s in-
struction (Roche, Indianapolis, USA). PCR products used
for DNA sequencing were gel purified using QIAquick®
gel extraction kit according to the manufacturer’s instruc-
tion (Qiagen, Venlo, Netherlands). DNA sequencing was
performed in both directions by use of an ABI Prism
BigDye Terminator v3.1 Cycle Sequencing Ready Reaction
kit (Applied Biosystems, Carlsbad, California, USA) and
an Applied Biosystems Genetic Analyzer DNA Model
3130X. Sequences obtained from both directions were
assembled and checked for accuracy with SeqMan®
(Lasergene®, Version 9; DNASTAR, Inc.). Pairwise nu-
cleotide sequence alignments were performed using the
Martinez-NWmethod [24] and the Lipman-Pearson method
[25] for protein alignments in MegAlign® (Lasergene).
3D structural analyses
Molecular graphics coordinates of the FMDV O1/BFS1860
crystal structure (PDB # 1FOD) [26] were manipulated
with the UCSF Chimera package from the Resource for
Biocomputing, Visualization, and Informatics at the
University of California, San Francisco [27]. The resulting
images were imported into Adobe Photoshop for editing.Competing interests
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